AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
BTIG Trims PT on AtriCure (ATRC) to $19; Management 'Disconnect' Causes Concern
August 8, 2016 11:17 AM EDTBTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 results late last week.
Analyst Sean Lavin commented, ATRC reported a relatively in-line but messy quarter with the core business coming in soft while increased focus on nContact... More
Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy
August 5, 2016 8:34 AM EDTNeedham & Company maintained a Buy rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $20.00 (from $23.00), following the company's 2Q earnings report. Revenue was reported at $39.7M, a slight beat to the consensus estimate of $39.8M. EPS was ($0.26), ahead of consensus of ($0.30). ATRC lowered its... More
AtriCure (ATRC) Tops Q2 EPS by 4c
August 4, 2016 5:16 PM EDTAtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $39.84 million.
"We are pleased to report second quarter results which reflect many accomplishments we launched two new... More